Financial Year |
March 31 2023 |
Monetary Funds |
217,472,481.21 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
18,265,823.87 |
Accounts Receivable |
313,953,246.14 |
Advances to Suppliers |
32,704,296.90 |
Other Receivables |
3,749,394.85 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
182,503,771.12 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
8,860,307.44 |
Total Current Assets |
828,129,159.27 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
128,666,966.49 |
Under-construction Projects |
15,409,987.02 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
34,468,323.83 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
14,091,249.31 |
Deferred Income Tax Assets |
17,838,900.86 |
Other Non-Current Assets |
46,700,599.72 |
Sub-Total of Non-Current Assets |
298,513,341.56 |
Total Assets |
1,126,642,500.83 |
Short-Term Loans |
34,247,554.00 |
Trading Financial liabilities |
-- |
Notes Payable |
29,304,624.56 |
Accounts Payable |
77,403,993.48 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
16,988,686.88 |
Taxes Payable |
13,542,006.32 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
36,054,201.97 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
7,322,817.77 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
216,721,806.22 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
39,812,436.90 |
Total Liabilities |
256,534,243.12 |
Paid-In Capital(Or Share Stock) |
78,430,822.00 |
Capital Surplus |
536,412,106.54 |
Surplus Reserve |
28,106,137.92 |
LESS:Treasury Stock |
35,990,500.00 |
Undistributed Profits |
252,085,962.37 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
870,108,257.71 |
Owner's Equity(Stockholder's Equity) |
870,108,257.71 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,126,642,500.83 |